Archives
TP53 Mutation, FTH, and Ferroptosis in Glioblastoma
2026-09-30
The reference study identifies an iron-homeostasis mechanism linking TP53 gain-of-function signaling to reduced ferritin heavy chain (FTH), increased labile iron, and ferroptosis sensitivity in glioblastoma models. Its findings support a genotype-informed strategy in which iron loading and ferroptosis induction are studied together, while also highlighting the need to validate the mechanism in clinically representative tumor systems.
DNMT3B and Neuroendocrine Prostate Cancer Plasticity
2026-09-30
The reference study identifies DNMT3B as a driver of therapy-associated neuroendocrine lineage plasticity and stemness in prostate cancer. Genetic depletion and pharmacologic inhibition with Nanaomycin A reduced neuroendocrine prostate cancer growth in preclinical models, supporting DNMT3B as a candidate target for treatment-resistant disease.
H-151 Links STING Inhibition to Ferroptosis Control
2026-09-29
The reference study shows that H-151, traditionally used as a covalent STING inhibitor, also suppresses ferroptosis through STING-independent radical-trapping antioxidant activity. By combining inflammatory pathway inhibition with protection against lipid peroxidation, H-151 reduced renal ischemia-reperfusion injury in mice and provides a mechanistic rationale for dual-pathway intervention.
TP53, FTH, and Ferroptosis in Glioblastoma
2026-09-29
This study identifies a TP53 mutation–associated iron imbalance in glioblastoma in which increased ITCH expression promotes FTH degradation and raises intracellular free iron. The resulting state creates a potential ferroptosis vulnerability, particularly when iron loading is combined with Erastin, while also highlighting important limits of translating astrocyte and database findings into patient treatment strategies.
Minoxidil sulphate: A Renal Vascular Assay Lens
2026-09-28
Minoxidil sulphate can serve as a mechanistic probe for potassium-channel and vasodilation research. This article translates renal sepsis findings into practical assay decisions while separating evidence-based interpretation from unvalidated extrapolation.
Caspase-3 Fluorometric Assay Kit in RCC Research
2026-09-28
Track DEVD-dependent caspase activity in resveratrol-treated renal cancer cells with a fast fluorescence readout. This guide connects the 786-O cell study to practical controls, assay setup, and troubleshooting—while clarifying what the signal can and cannot establish about apoptosis.
DNMT3B Drives Neuroendocrine Prostate Cancer Plasticity
2026-09-27
The study identifies DNMT3B as a driver of neuroendocrine and stemness-associated programs in treatment-resistant prostate cancer, and reports that genetic or pharmacologic inhibition suppresses NEPC features and tumor growth in experimental models. Its findings position DNMT3B as a candidate target for further study, while leaving important questions about mechanism, treatment parameters, and clinical relevance unresolved.
H-151 Blocks Ferroptosis Beyond STING Inhibition
2026-09-26
The study reports that H-151, a covalent STING inhibitor, also acts as a radical-trapping antioxidant and suppresses ferroptosis independently of STING. In a murine renal ischemia-reperfusion injury model, its combined effects on inflammatory signaling and ferroptotic damage were associated with improved tissue injury and renal function, suggesting a dual-pathway strategy for further study.
Staurosporine in Assay Design for Lens Aging Research
2026-09-25
Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor whose effects require careful interpretation in cell-based research. This article connects kinase perturbation assay design with new findings on GCLC truncation and age-related cataract—while clarifying what the evidence does and does not establish.
H-151 Links STING Inhibition to Ferroptosis Control
2026-09-25
Yin and colleagues report that H-151, a covalent STING inhibitor, also suppresses ferroptosis by trapping radicals independently of STING. In a murine renal ischemia-reperfusion injury model, the compound’s combined effects on inflammatory signaling and lipid peroxidation were associated with less tissue damage and improved renal function, suggesting a dual-pathway strategy that merits further testing.
Autophagy Buffers Resveratrol-Induced Apoptosis in RCC
2026-09-24
In renal carcinoma 786-O cells, resveratrol damaged mitochondria and triggered ROS-associated, caspase-3-dependent apoptosis, while ROS–JNK signaling also induced autophagy. Pharmacological or genetic inhibition of autophagy increased apoptosis, identifying a potential survival response that may be relevant to combination strategies but requires validation beyond this single-cell-line model.
Vincristine Sulfate: Practical Cancer Research Workflows
2026-09-24
Build reproducible vincristine experiments around its microtubule-disrupting action, with guidance for stock preparation, dose-response design, and orthogonal readouts. This workflow separates product-specific evidence from practical starting conditions and clearly distinguishes vincristine research from unrelated findings on inflammation.
TP53 Mutations, FTH, and Ferroptosis in Glioblastoma
2026-09-23
A 2025 study links TP53-mutant gain of function to increased ITCH expression, degradation of the iron-storage protein FTH, and altered iron handling in glioblastoma models. The findings suggest that reduced ferritin storage can make cells more vulnerable to Erastin-induced ferroptosis, particularly when iron availability is increased, while leaving important questions about model and treatment transferability.
miRNA–mRNA Control of Juvenile Hormone Biosynthesis
2026-09-23
The reference study identifies coordinated miRNA–mRNA modules that regulate juvenile hormone biosynthetic genes in locust corpora allata during vitellogenesis. Its combination of transcriptomics, target validation, and agomiR perturbation links small-RNA regulation with juvenile hormone-dependent vitellogenin expression and ovarian development.
Cyclic di-GMP Controls Biofilm Persistence via HipH
2026-09-22
Liao et al. identify cyclic di-GMP as a small-molecule antitoxin that restrains the genotoxic toxin HipH during biofilm development. Their findings connect adhesion-stage signaling with DNA double-strand breaks, genome instability, and antibiotic persistence, expanding the mechanistic framework for biofilm resilience.